post-discharge support to help prevent readmission.

Size: px
Start display at page:

Download "post-discharge support to help prevent readmission."

Transcription

1 Retrospective Cohort Study of Medication Adherence And Risk for 30-day Hospital Readmission in a Medicare Cost Plan Angela K. Hochhalter, PhD; Rashmita Basu, PhD; Karim Prasla, PharmD; and Chanhee Jo, PhD ABSTRACT Purpose: Reducing hospital readmissions requires deploying appropriate interventions to groups at highest risk for readmission. Longterm medication adherence may indicate one s ability to manage recovery and chronic illness after discharge. If so, medication adherence also may be a predictor of hospital readmission. Design: The objective of this study was to test the association of longterm medication adherence with hospital readmission in a cohort of beneficiaries enrolled in a Medicare Cost Plan. Methodology: The study employed a retrospective cohort design using administrative pharmacy and health care claims for a sample hospitalized in Medication adherence was measured with the medication possession ratio (MPR) for the 12 months prior to the first hospitalization in The likelihood of readmission Corresponding author Angela K. Hochhalter, PhD Assistant Professor Department of Internal Medicine Scott & White Healthcare and Texas A&M Health Science Center 2401 South 31st St. (CDM) MS-34-M1254 Temple, TX (254) ahochhalter@swmail.sw.org Disclosures: All authors are employees of the health care system that includes the health plan in which participants were members. The authors report no financial or other conflicts of interest regarding the subject of this article. within 30 days from the first hospitalization in 2009 was estimated using the logistic regression model. Results: Long-term medication adherence was not associated with likelihood of 30-day hospital readmission (odds ratio [OR]=0.82, P=.71). However, older age (OR=1.07, P=.003) and longer length of hospital stay (OR=1.2, P<.001) were associated with higher likelihood of 30-day readmission, while having an office visit within 30 days of discharge (OR=0.38, P=.03) was associated with lower odds of readmission. Conclusion: Except for older age, variables associated with likelihood of readmission are difficult for clinical teams to access during a hospital stay to identify those at risk for readmission. Additional work is needed to identify indicators of readmission risk that can be utilized during hospitalization to identify patients needing post-discharge support to help prevent readmission. INTRODUCTION Transitions from hospitals back to patient homes pose risks for adverse events that lead to costly hospital readmission (Amin 2009, Boling 2009, Tsilimingrad 2008). Older adults are particularly vulnerable to hospital readmission because many have complex care needs that require careful coordination by health care providers and systems in addition to illness self-management (Jencks 2009, Ross 2009). For example, approximately half of discrepancies between medications prescribed at hospital discharge and medications elderly consumers report taking have been classified as associated with intentional or unintentional nonadherence (Coleman 2005). The majority of evidence on hospital-to-home transitions speaks to the role of health systems and practitioners. Transitional care interventions have extended the practice team s presence into patient homes or nursing homes. For example, nurses may follow patients after discharge and provide supportive care and clinical guidance (Harrison 2002, Naylor 1999), coaches may work with patients to empower self-management, or tools for improved hospital-nursing home communication may be adopted (Coleman 2006, Ouslander 2009, Parry 2009). Effective interventions incorporate support or training for patients and families to carry out tasks that are important to the success of the hospital-to-home transition (eg, watching for signs of illness exacerbation, adhering to new medication regimens, communicating with outpatient clinicians). While it is assumed that patients play an important role in successful transitions, little is known about how patients manage the challenges of transitions in care, which health behaviors are most effective for avoiding readmission, or which consumers need additional support to actively manage challenges at home. Empirical findings show that that medication management after hospital discharge is a serious challenge for many older adults. Older adults are at higher risk than other age groups for self-discontinuation of certain medications following hospitalization because they report feeling worse on the medication, feeling that medications are not helping, or being unable to JANUARY 2014 / MANAGED CARE 43

2 afford prescribed medications (Ali 2009). Li and colleagues (2004) found that after controlling for use of paid or unpaid nursing care, assistance with daily activities, and other factors, illness duration and self-reported recent medication adherence were consistent predictors of hospital readmission for elderly consumers with congestive heart failure. There is also evidence that better long-term medication adherence is associated with lower use of hospital services among populations without Medicare coverage. For example, Pitt man and colleagues (2010) reported that adults aged 18 to 63 years with hypertension and high adherence to antihypertensive medication (per administrative billing records) had lower health care costs and fewer hospitalizations for cardiovascular-related events. Medication adherence may be an indicator of overall engagement in self-management or other healthy behaviors important for mitigating vulnerability to readmission after hospital discharge. It is well documented that persons who are more adherent to medications also tend to show better health outcomes. For example, Simpson and colleagues (2006) reported lower odds of mortality for good versus poor adherence to beneficial drug therapies (pooled odds ratio [OR] =0.55) and placebo (pooled OR=0.45) in a meta-analysis of 21 studies, suggesting that persons who adhere to medication may also be healthier in general or that adherence may be a surrogate for healthy behavior in general. Given the importance of health behaviors during transitions from hospitals to homes and given evidence that long-term medication adherence is associated with use of hospital services in some populations, we hypothesized that poorer long-term medication adherence may also be associated with higher risk for hospital readmission. The purpose of TABLE 1 Member characteristics and index hospitalization characteristics Variable N Percent Study sample 721 Gender Female % Male % Age Minimum 27 Mean 77 Maximum 98 Length of stay (days) Minimum 1 Mean 3.6 Maximum 77 Office visit within 30 days Yes % No % this retrospective cohort study was therefore to examine associations between long-term medication adherence and 30-day hospital readmission in a population of Medicare Cost Plan members in Central Texas. If poorer long-term medication adherence is associated with higher risk for readmission after hospital discharge, health care providers and systems may be able to leverage this information to better-target needed intervention to reduce readmissions. METHOD Study population. Members of Scott & White Health Plan SeniorCare, a Medicare Cost Plan, 1 were eligible for study inclusion if they met the following criteria: were hospitalized at least once in 2009; if at least 1 pharmacy claim for a chronic condition 1 A Medicare Cost Plan is a type of Medicare plan that provides full coverage (usually Part A and B, sometimes also Part D). Payment is based on reasonable cost of services. Beneficiaries are not restricted to a limited network of providers. medication (see Table 1) was available for the 12 months prior to the index hospitalization in 2009; if they were continuously enrolled in the product for the full study period; and if they were discharged to home after the initial hospital admission. A total of 1243 members were identified to have at least one hospitalization in the year 2009 with the discharge status of home. Forty-nine members, who had index hospitalization after Nov. 30, 2009, and no readmission before December 2009, were excluded to avoid selection bias from truncating the time available for readmission to less than 30 days. The sample of eligible members was This sample was further reduced to 721 after linking to pharmacy claims for prescription drug utilization during a 12-month period before the index hospitalization. The study protocol was reviewed and approved by the Scott & White Healthcare Institutional Review Board. Data sources. Electronic administrative claims data for pharmacy, inpatient services, and outpatient ser- 44 MANAGED CARE / JANUARY 2014

3 vices during the study period were extracted for each eligible member. Inpatient hospital admission for any reason was identified based on the presence of a facility claim for an inpatient hospital stay (Mapel 2011). Outpatient visits were identified by CPT codes (medical evaluation and management) for new and established patients. Variables. Member characteristics included gender and age. Characteristics of the first hospitalization in 2009 the index hospitalization included length of stay and discharge disposition (routine discharge to home). The outcome variable of interest was readmission within 30 days of the index discharge. Length of stay for the index hospitalization was calculated by the difference between the admission date and the discharge date for the index hospitalization. Office visits within 30 days of discharge from the index hospitalization were identified by a date of service within 30 calendar days of the index discharge date. Office visits were treated as dichotomous (Yes, visit within 30 days or No, no documented visit within 30 days). Medication adherence for the 12 months before the admission date for the index hospitalization was measured by the medication possession ratio (MPR), a well-accepted methodology to assess medication use with administrative pharmacy claims data (Hess 2006, Steiner 1997). MPR is a ratio from 0.0 (ie, lowest) to 1.0 (perfect adherence). Values were capped at 1.0. Adherence was considered low if the MPR was less than 0.5, medium if between 0.5 and 0.79, and high if TABLE 2 Medication adherence among members in the study sample (N=721) MPR (%) Low (<0.5) Medium ( ) High (0.8 1) greater than 0.8 (Balkrishnan 2003, Lau 2004, Psaty 2001, Wei 2002). MPR was calculated for 5 classes of medication relevant to management of common chronic illnesses: antidepressant, antihyperlipidemic, antiarrhythmic, antihypertensive, and diabetes medications. The drug categories were identified based on the American Hospital Formulary Service (AHFS) codes. Each individual drug within the AHFS category was identified based on the generic code number (GCN). MPR was calculated for medications with at least 2 pharmacy claims for the same GCN. For AHFS and GCN codes, see online version of this article at com/mc1401-adherence. MPR was calculated by determining the total number of numerator and denominator days in the 12 months prior to the index hospitalization. MPR was further categorized by different drugs taken by a particular patient during the study period. Drugs were grouped based on the generic product identifier (GPI) code, excluding the last 2 digits. Denominator days were calculated by the difference between prescription filled date and the date of first hospitalization for all prescription medications in different drug categories. Finally, the sum of the maximum number of denominator days for each drug group was calculated. Numerator days of supply were calculated in 2 steps. First, we identified the total number of days of prescription medication supplied (for which claims were filed during the analysis period) for each drug category and summed the total days supplied. Second, we subtracted the carryover days of supplied drugs that fell beyond the analysis period. This gave us the total number of numerator days. The MPR was calculated by dividing the total number of numerator days by the total number of denominator days. Dose changes were treated as continuation of therapy rather than a new medication. Among 1192 patients, pharmacy claims data were identified for 722 patients during the 12-month period prior to the index hospitalization in Therefore, our analysis includes 722 patients who experienced at least 1 inpatient hospitalization in 2009 and pharmacy claims 12 months prior to the index hospitalization. Statistical analysis. Member characteristics were tabulated or summarized by mean and range. The likelihood of 30-day rehospitalization was estimated using the logistic regression technique, where rehospitalization status within 30 days was a function of age, gender, length of stay at the first hospitalization, office visits within 30 calendar days of the discharge date for the index hospitalization. Analyses were performed in SAS 9.2 (SAS Institute, Cary, NC). P values <.05 were considered statistically significant. RESULTS Table 1 shows study sample characteristics. The average age was 76 (range: years). Sixty-five percent of the sample was female. The average length of stay for the index hospitalization was 4 days (range 1 77 days). Approximately 85% of members attended an office visit within 30 days from the date of discharge from the index hospitalization. Table 2 presents the 12-month medication adherence for the study sample. About 14% of members had low medication adherence, about 30% had medium adherence, and 56% had high adherence based on MPR scores JANUARY 2014 / MANAGED CARE 45

4 prior to index hospitalization. The mean MPR was 0.78 (range ). Only 43 of 721 health plan members experienced a hospital readmission within 30 days of index hospital discharge. Table 3 shows the OR estimates for the likelihood of 30-day readmission estimated with logistic regression. Increased age (OR=1.07, P=.003) and longer length of stay for the index admission (OR=1.2, P<.001) were associated with higher likelihood of 30-day readmission. Compared with those who did not have an office visit within 30 days of the index discharge, the odds of 30- day readmission was lower for those with an office visit (OR=0.38, P=.03). Individuals with low medication adherence (MPR <0.5) were not more likely to experience 30-day readmission compared with those who had higher medication adherence (MPR >0.8). DISCUSSION Contrary to expectations, longterm medication adherence prior to the index hospitalization was not associated with likelihood of 30-day readmission in the study sample of members of a Medicare cost plan. Older age and longer length of stay were associated with higher likelihood of readmission; follow-up office visit was associated with lower likelihood of readmission. Limitations. The study sample may not be representative of all Medicare populations. Because of limitations in the available dataset, we are unable to provide detailed characteristics of the sample to include income, race/ ethnicity, marital status, and other variables that may be associated with health and health behaviors. Overall long-term medication adherence was relatively high (mean = -.78) and only 14% of the sample had low adherence based on MPR scores. In addition, the 30-day readmission rate for the group was low relative to general Medicare TABLE 3 Logistic regression model for 30-day readmission after index hospitalization in Day Readmission Parameter Odds Ratio 95% CI P-Value Age <.003 Office visits Length of stay <.001 MPR-low samples (Jencks 2009). Administrative claims data only capture information reported by providers to the cost plan payer. Pharmacy claims may miss prescriptions filled at pharmacies that do not submit claims to this payer (eg, self-paid prescription fills). The MPR measure of adherence does not capture whether members actually take medications as prescribed, but the measure has been validated and is a well-accepted method of capturing adherence (Andrade 2006, Steiner 1997). Medication errors are a wellknown contributor to safety risks and readmission following hospital discharge (Coleman 2005, Forster 2003, Marcum 2010). This study does not address how members adhered to medications in the weeks following discharge. In this study we selected classes of drugs commonly used for long-term treatment of chronic conditions. It is possible that adherence calculated on only the selected categories did not fully represent individuals long-term adherence behaviors. CONCLUSION Reducing hospital readmissions is a national health care priority. Interventions are available to help address patient needs in the time following hospital discharge, but these interventions require resources. Efficient use of those resources may be enhanced by successful identification of patient characteristics or behaviors that predict risk for readmission. To date, many of the variables that have been associated with readmission may be difficult or impossible for inpatient clinicians to easily identify before hospital discharge. For example, length of stay and attending a post-discharge office visit were associated with readmission in this study but these variables obviously are not available to clinicians who begin planning for hospital discharge arrangements early in a hospital stay (because at this point the length of stay has yet to be determined and the post-office visit has not yet occurred). In this study, long-term medication adherence was not a predictor of readmission for a sample that was relatively adherent to medications before admission and may have been generally prepared for post-discharge challenges. Additional work is needed to identify indicators of readmission risk that can be utilized during hospitalization to identify patients needing post-discharge support to help prevent readmission. REFERENCES Ali RC, Melloni C, Ou FS, Schmader K, Ohman EM, Roe MT, et al. Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time. J Am Geriatr Soc. 2009;57(11): Amin AP, Mukhopadhyay E, Nathan S, Napan S, Kelly RF. Association of medical noncompliance and longterm adverse outcomes, after myocardial infarction in a minority and 46 MANAGED CARE / JANUARY 2014

5 uninsured population. Transl Res. 2009;154(2): Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8): ; discussion Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11): Boling PA. Care transitions and home health care. Clin Geriatr Med. 2009;25(1): , viii. Coleman EA, Parry C, Chalmers S, Min SJ. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med. 2006;166(17): Coleman E, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: Prevalence and contributing factors. Arch Intern Med. 2005;165: Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003;138(3): Harrison MB, Browne GB, Roberts J, Tugwell P, Gafni A, Graham ID. Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition. Med Care. 2002;40(4): Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40(7 8): Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14): Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9): Li H, Morrow-Howell N, Proctor EK. Postacute home care and hospital readmission of elderly patients with congestive heart failure. Health Soc Work. 2004;29(4): Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B. Identifying and characterizing COPD patients in US managed care. A retrospective, crosssectional analysis of administrative claims data. BMC Health Serv Res. 2011;11:43. Marcum ZA, Handler SM, Boyce R, Gellad W, Hanlon JT. Medication misadventures in the elderly: a year in review. Am J Geriatr Pharmacother. 2010;8(1): Naylor MD, Brooten D, Campbell R, Jacobsen BS, Mezey MD, Pauly MV, et al. Comprehensive discharge planning and home follow-up of hospitalized elders. JAMA. 1999;281(7): Ouslander JG, Perloe M, Givens JH, Kluge L, Rutland T, Lamb G. Reducing potentially avoidable hospitalizations of nursing home residents: results of a pilot quality improvement project. J Am Med Dir Assoc. 2009;10(9): Parry C, Min SJ, Chugh A, Chalmers S, Coleman EA. Further application of the care transitions intervention: results of a randomized controlled trial conducted in a fee-for-service setting. Home Health Care Serv Q. 2009;28(2 3): Psaty BM, Furberg CD, Kuller LH, Cushman M, Savage PJ, Levine D et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: the cardiovascular health study. Arch Intern Med. 2001;161(9): Pittman DG, Tao Z, Chen W, Stettin GD. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care. 2010;16(8): Ross JS, Chen J, Lin Z, Bueno H, Curtis JP, Keenan PS, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2009;3(1): Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1): Tsilimingras D, Bates DW. Addressing postdischarge adverse events: a neglected area. Jt Comm J Qual Patient Saf. 2008;34(2): Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart. 2002;88(3): JANUARY 2014 / MANAGED CARE 47

CHF Longitudinal Workgroup. Addressing readmissions from SNFs and other PAC settings 3/2/17

CHF Longitudinal Workgroup. Addressing readmissions from SNFs and other PAC settings 3/2/17 CHF Longitudinal Workgroup Addressing readmissions from SNFs and other PAC settings 3/2/17 Readmission Rate (%) Readmission Rate from SNF by Hospital (CHF) 16 14 13.6% 12 10 8 6 4 2 0 Mean = 6.3% 0% 0

More information

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education Robyn Tamblyn, BScN, MSc, PhD, CM Disclosure None of the above speakers have any conflicts

More information

The PREDICT Trial. Prediction using a Randomized Evaluation of Data collection Integrated through Connected Technologies

The PREDICT Trial. Prediction using a Randomized Evaluation of Data collection Integrated through Connected Technologies The PREDICT Trial Prediction using a Randomized Evaluation of Data collection Integrated through Connected Technologies Ogochukwu Ufio Advisors: Mitesh Patel MD, MBA, MS Caroline Carney, BA Table of Contents

More information

By 2030, the number of seniors in the United States

By 2030, the number of seniors in the United States Patient Characteristics and Medication Burden Affect Adherence Among Seniors Drug Trends R. Scott Leslie, MPH; Sara C. Erickson, PharmD; and Bimal V. Patel, PharmD, MS By 2030, the number of seniors in

More information

H2H Early Follow-up Challenge: See You in 7. Webinar #1 Thursday, March 3, :00 pm 4:00 pm ET. Welcome

H2H Early Follow-up Challenge: See You in 7. Webinar #1 Thursday, March 3, :00 pm 4:00 pm ET. Welcome H2H Early Follow-up Challenge: See You in 7 Webinar #1 Thursday, March 3, 2011 3:00 pm 4:00 pm ET 1 Welcome Take Home Messages Renew your H2H commitment Participate in the first H2H Challenge Help build

More information

Hospital Transition Management. Barbara Wood, BSN, MBA

Hospital Transition Management. Barbara Wood, BSN, MBA Hospital Transition Management Barbara Wood, BSN, MBA Director, Embedded Care Management Programs OBJECTIVES Improve health care quality for our patients by streamlining care transitions Reduce avoidable

More information

Do Elderly Men Have Increased Mortality Following Hip Fracture?

Do Elderly Men Have Increased Mortality Following Hip Fracture? Do Elderly Men Have Increased Mortality Following Hip Fracture? Excess Mortality in Men Compared With Women Following a Hip Fracture. National Analysis of Comedications, Comorbidity and Survival. Kannegaard

More information

METHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC

METHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC PREDICTORS OF MEDICATION ADHERENCE AMONG PATIENTS WITH SCHIZOPHRENIC DISORDERS TREATED WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS IN A LARGE STATE MEDICAID PROGRAM S.P. Lee 1 ; K. Lang 2 ; J. Jackel 2 ;

More information

HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES

HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES HEALTH CARE EXPENDITURES ASSOCIATED WITH PERSISTENT EMERGENCY DEPARTMENT USE: A MULTI-STATE ANALYSIS OF MEDICAID BENEFICIARIES Presented by Parul Agarwal, PhD MPH 1,2 Thomas K Bias, PhD 3 Usha Sambamoorthi,

More information

Unplanned 30-Day Readmissions in Orthopaedic Trauma

Unplanned 30-Day Readmissions in Orthopaedic Trauma Unplanned 30-Day Readmissions in Orthopaedic Trauma Introduction: 30-day readmission is increasingly used as a hospital quality metric. The objective of this study was to describe the patient factors associated

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life

More information

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Megan Willson, PharmD, BCPS; Catrina Schwartz, PharmD, BS; Jennifer Robinson, PharmD Spokane,

More information

ARIC Manuscript Proposal #2493. PC Reviewed: 2/10/15 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #2493. PC Reviewed: 2/10/15 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal #2493 PC Reviewed: 2/10/15 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Potentially inappropriate medication use in older people: Prevalence and outcomes.

More information

Payers continue to search for effective ways to control

Payers continue to search for effective ways to control At a Glance Practical Implications p 218 Author Information p 221 Full text and PDF www.ajpblive.com Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and Diabetes Benefit

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set

More information

The University of Mississippi School of Pharmacy

The University of Mississippi School of Pharmacy LONG TERM PERSISTENCE WITH ACEI/ARB THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: AN ANALYSIS OF THE 2006-2007 MEDICARE 5% NATIONAL SAMPLE DATA Lokhandwala T. MS, Yang Y. PhD, Thumula V. MS, Bentley J.P.

More information

The Effect of Statin Therapy on Risk of Intracranial Hemorrhage

The Effect of Statin Therapy on Risk of Intracranial Hemorrhage The Effect of Statin Therapy on Risk of Intracranial Hemorrhage JENNIFER HANIFY, PHARM.D. PGY2 CRITICAL CARE RESIDENT UF HEALTH JACKSONVILLE JANUARY 23 RD 2016 Objectives Review benefits of statin therapy

More information

Changing Patterns in Medication Use with Increasing Probability of Death for Older Medicare Beneficiaries

Changing Patterns in Medication Use with Increasing Probability of Death for Older Medicare Beneficiaries Changing Patterns in Medication Use with Increasing Probability of Death for Older Medicare Beneficiaries Thomas Shaffer, MHS; Linda Simoni-Wastila, PhD, Wendy Toler, PharmD, Bruce Stuart, PhD, and Jalpa

More information

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

LAIs and the Challenge of Medication Non-Adherence The Care Transitions Network

LAIs and the Challenge of Medication Non-Adherence The Care Transitions Network LAIs and the Challenge of Medication Non-Adherence The Care Transitions Network Lauren Hanna, M.D. The Zucker Hillside Hospital Northwell Health National Council for Behavioral Health Montefiore Medical

More information

CLINICAL. Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population

CLINICAL. Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population Determinants of Compliance With Statin Therapy and Low-Density Lipoprotein Cholesterol Goal Attainment in a Managed Care Population Jennifer S. Schultz, PhD; John C. O Donnell, PhD; Ken L. McDonough, MD;

More information

Using claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center

Using claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Using claims data to investigate RT use at the end of life B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Background 25% of Medicare budget spent on the last year of life.

More information

outcome measures were adherence, medication possession ratio (MPR), persistence, prescription count, and duration of therapy.

outcome measures were adherence, medication possession ratio (MPR), persistence, prescription count, and duration of therapy. ORIGINAL RESEARCH Patient Adherence with HMG Reductase Inhibitor Therapy among Users of Two Types of Prescription Services by T. Jeffrey White, Pharm.D., M.S., Eunice Chang, Ph.D., Scott Leslie, M.P.H.,

More information

4/26/2016 DISCLOSURES BACKGROUND OBJECTIVES BACKGROUND BACKGROUND

4/26/2016 DISCLOSURES BACKGROUND OBJECTIVES BACKGROUND BACKGROUND http://thinkprogress.org/health/01/10//1061/how-rising-health-care-costs-impact-the-national-budget/ http://www.firstaidforfree.com/wp-content/uploads/015/09/falls.jpg http://drwills.com/wp-content/uploads/015/05/drugcycle.jpg

More information

Getting Hypertension Under Control

Getting Hypertension Under Control Getting Hypertension Under Control Learning Objectives EXPLAIN the factors involved in patient medication non-adherence. OUTLINE the results of studies focusing on medication adherence issues in patients

More information

Performance Outcomes: Measure & Metric Details

Performance Outcomes: Measure & Metric Details Performance Outcomes: Measure & Metric Details Adherence to Antipsychotic Medications for People with Schizophrenia Numerator: Number of people who remained on an antipsychotic for at least 80% of their

More information

Parental Perception of Quality of Hospital Care for Children with Sickle Cell Disease

Parental Perception of Quality of Hospital Care for Children with Sickle Cell Disease Parental Perception of Quality of Hospital Care for Children with Sickle Cell Disease Jared Kam, BS; Julie A. Panepinto, MD, MSPH; Amanda M. Brandow, DO; David C. Brousseau, MD, MS Abstract Problem Considered:

More information

Patient Safety in Older Adults

Patient Safety in Older Adults Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical

More information

Patient Safety in Older Adults

Patient Safety in Older Adults Patient Safety in Older Adults Scott Martin Vouri, PharmD, MSCI, BCPS, BCGP, FASCP St. Louis College of Pharmacy Faculty Disclosure Dr. Vouri is funded by the Washington University Institute of Clinical

More information

Role of Pharmacoepidemiology in Drug Evaluation

Role of Pharmacoepidemiology in Drug Evaluation Role of Pharmacoepidemiology in Drug Evaluation Martin Wong MD, MPH School of Public Health and Primary Care Faculty of Medicine Chinese University of Hog Kong Outline of Content Introduction: what is

More information

PDE File Medication Utilization; Medication Possession Ratio. Kyoungrae Jung, Ph.D. Assistant Professor Penn State University

PDE File Medication Utilization; Medication Possession Ratio. Kyoungrae Jung, Ph.D. Assistant Professor Penn State University PDE File Medication Utilization; Medication Possession Ratio Kyoungrae Jung, Ph.D. Assistant Professor Penn State University Outline PDE variables related to medication utilization Measures of medication

More information

The Healthy User Effect: Ubiquitous and Uncontrollable S. R. Majumdar, MD MPH FRCPC FACP

The Healthy User Effect: Ubiquitous and Uncontrollable S. R. Majumdar, MD MPH FRCPC FACP The Healthy User Effect: Ubiquitous and Uncontrollable S. R. Majumdar, MD MPH FRCPC FACP Professor of Medicine, Endowed Chair in Patient Health Management, Health Scholar of the Alberta Heritage Foundation,

More information

Murthy Gokula MD,CMD

Murthy Gokula MD,CMD Murthy Gokula MD,CMD MEDICATIONS & LIFE EXPECTANCY DON T ROUTINELY PRESCRIBE LIPID-LOWERING MEDICATIONS IN INDIVIDUALS WITH A LIMITED LIFE EXPECTANCY: AAHPM About Choosing Wisely First conceived by the

More information

Quality Outcomes and Financial Benefits of Nutrition Intervention. Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition

Quality Outcomes and Financial Benefits of Nutrition Intervention. Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition Quality Outcomes and Financial Benefits of Nutrition Intervention Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition January 28, 2016 SHIFTING MARKET DYNAMICS PROVIDE AN OPPORTUNITY

More information

Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications

Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications MWSUG 2017 - Paper DG02 Exploring the Relationship Between Substance Abuse and Dependence Disorders and Discharge Status: Results and Implications ABSTRACT Deanna Naomi Schreiber-Gregory, Henry M Jackson

More information

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help William Shrank MD MSHS Division of Pharmacoepidemiology & Pharmacoeconomics Harvard Medical School wshrank@partners.org

More information

Cost-Motivated Treatment Changes in Commercial Claims:

Cost-Motivated Treatment Changes in Commercial Claims: Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non- Medical Switching August 2017 THE MORAN COMPANY 1 Cost-Motivated Treatment Changes in Commercial Claims: Implications for Non-Medical

More information

Follow this and additional works at:

Follow this and additional works at: The University of Toledo The University of Toledo Digital Repository Theses and Dissertations 2013 Factors associated with primary medication nonadherence and its effect on health service utilization among

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Search terms*

SUPPLEMENTARY DATA. Supplementary Figure S1. Search terms* Supplementary Figure S1. Search terms* *mh = exploded MeSH: Medical subject heading (Medline medical index term); tw = text word; pt = publication type; the asterisk (*) stands for any character(s) #1:

More information

Adherence to therapy. Kamlesh Khunti University of Leicester, UK. William Polonsky University of California San Diego, USA

Adherence to therapy. Kamlesh Khunti University of Leicester, UK. William Polonsky University of California San Diego, USA Adherence to therapy Kamlesh Khunti University of Leicester, UK William Polonsky University of California San Diego, USA 1 Dualities of interest Kamlesh Khunti: Honoraria for speaking, advising or research

More information

A Prospective Comparison of Two Commercially Available Hospital Admission Risk Scores

A Prospective Comparison of Two Commercially Available Hospital Admission Risk Scores A Prospective Comparison of Two Commercially Available Hospital Admission Risk Scores Dale Eric Green, MD MHA FCCP: Chief Medical Information Officer, Cornerstone Health Care AMGA April, 2014 Disclosure

More information

Background. Background. Background 3/14/2014. Conflict of Interest Statement:

Background. Background. Background 3/14/2014. Conflict of Interest Statement: Platform Presentations Comparison of zolpidem to other drugs associated with falls in hospitalized patients Ed Rainville, MSPharm. Conflict of Interest Statement: The speaker has no conflict of interest

More information

Real World Patients: The Intersection of Real World Evidence and Episode of Care Analytics

Real World Patients: The Intersection of Real World Evidence and Episode of Care Analytics PharmaSUG 2018 - Paper RW-05 Real World Patients: The Intersection of Real World Evidence and Episode of Care Analytics David Olaleye and Youngjin Park, SAS Institute Inc. ABSTRACT SAS Institute recently

More information

Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD, MPH, PhD Professor Mark S. Dworkin MD, MPHTM The University of Illinois at Chicago

Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD, MPH, PhD Professor Mark S. Dworkin MD, MPHTM The University of Illinois at Chicago Less is More: The Impact of Lower Pill Burden on Adherence to Antiretroviral Therapy among Treatment-Naive Patients with HIV Infection in the United States Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD,

More information

Impact of hospitalization on medication adherence estimation in claims data

Impact of hospitalization on medication adherence estimation in claims data Received: 23 December 2016 Accepted: 15 February 2017 DOI: 10.1111/jcpt.12517 ORIGINAL ARTICLE Impact of hospitalization on medication adherence estimation in claims data Y.-H. Dong PhD 1,2,3 N. K. Choudhry

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With Over half of patients from the Medicare 5% sample (restricted to age 65 and older) have a diagnosis of chronic kidney disease (), cardiovascular disease,

More information

Changes for Physician Measurement 2018

Changes for Physician Measurement 2018 Changes for Physician Measurement 2018 Measure Name Guidelines for Physician Measurement Effectiveness of Care Changes Revised the Systematic Sampling Methodology to require organizations to report using

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lee JS, Nsa W, Hausmann LRM, et al. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med. Published online September

More information

Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report. User s Guide Sixth Edition. Prepared by

Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report. User s Guide Sixth Edition. Prepared by Partial Hospitalization Program Program for Evaluating Payment Patterns Electronic Report User s Guide Sixth Edition Prepared by Partial Hospitalization Program Program for Evaluating Payment Patterns

More information

Preventing 30-Day Rehospitalization Among Elderly Patients: Special Focus on a Primary Care NP-Led Transition of Care Intervention

Preventing 30-Day Rehospitalization Among Elderly Patients: Special Focus on a Primary Care NP-Led Transition of Care Intervention Preventing 30-Day Rehospitalization Among Elderly Patients: Special Focus on a Primary Care NP-Led Transition of Care Intervention Katie S. Wingate, DNP, AGNP-C 2017 NPSS Asheville, NC Presentation Outline

More information

A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity

A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity W.F. Gellad et al. The American Journal of Geriatric Pharmacotherapy A Systematic Review of Barriers to Medication Adherence in the Elderly: Looking Beyond Cost and Regimen Complexity Walid F. Gellad,

More information

Patient Navigator Program: Focus MI Diplomat Hospital Metrics

Patient Navigator Program: Focus MI Diplomat Hospital Metrics Patient Navigator Program: Focus MI Diplomat Hospital Metrics Goal Statement: To reduce avoidable hospital readmissions for patients discharged with acute myocardial infarction (AMI) by supporting a culture

More information

Predictors of Rehospitalization After Admission for Pneumonia in the Veterans Affairs Healthcare System

Predictors of Rehospitalization After Admission for Pneumonia in the Veterans Affairs Healthcare System ORIGINAL RESEARCH Predictors of Rehospitalization After Admission for Pneumonia in the Veterans Affairs Healthcare System Victoria L. Tang, MD 1,2, Ethan A. Halm, MD, MPH 2, Michael J. Fine, MD, MSc 3,

More information

Hospice and Palliative Care: Value-Based Care Near the End of Life

Hospice and Palliative Care: Value-Based Care Near the End of Life Hospice and Palliative Care: Value-Based Care Near the End of Life Mary Dittrich, MD, FASN Senior Medical Director, Remedy Partners Joseph W. Shega, MD National Medical Director, VITAS Healthcare 2017

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

Hospice and Palliative Care: Value-Based Care Near the End of Life

Hospice and Palliative Care: Value-Based Care Near the End of Life Hospice and Palliative Care: Value-Based Care Near the End of Life Mary Dittrich, MD, FASN Senior Medical Director, Remedy Partners Joseph W. Shega, MD National Medical Director, VITAS Healthcare 2017

More information

SPECIAL ISSUE. Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications

SPECIAL ISSUE. Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications Medicaid Prescription Drug Access Restrictions: Exploring the Effect on Patient Persistence With Hypertension Medications Jerome Wilson, PhD; Kirsten Axelsen, MS; and Simon Tang, MPH Objective: To compare

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

DOES PROCESS QUALITY OF INPATIENT CARE MATTER IN POTENTIALLY PREVENTABLE READMISSION RATES?

DOES PROCESS QUALITY OF INPATIENT CARE MATTER IN POTENTIALLY PREVENTABLE READMISSION RATES? DOES PROCESS QUALITY OF INPATIENT CARE MATTER IN POTENTIALLY PREVENTABLE READMISSION RATES? A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Jae Young Choi,

More information

Improve the Adherence, Save the Life

Improve the Adherence, Save the Life Improve the Adherence, Save the Life Park, Chang Gyu Korea University Guro Hospital Cardiovascular Center Seoul, Korea Modifiable CVD Risk Factors Obesity BMI Hypertension Cholesterol LDL HDL Diabetes

More information

Using Evidence to Support Recovery through Comprehensive Community Services (CCS) Presentation Objectives. What is CCS? 10/17/2018

Using Evidence to Support Recovery through Comprehensive Community Services (CCS) Presentation Objectives. What is CCS? 10/17/2018 Using Evidence to Support Recovery through Comprehensive Community Services (CCS) Chris Keenan and Tim Connor October 17, 2018 Presentation Objectives Understand the needs of CCS participants related to

More information

The US Food and Drug Administration (FDA) requires that

The US Food and Drug Administration (FDA) requires that Prescriber Compliance With Black Box Warnings in Older Adult Patients Judith A. Ricci, ScD, MS; Charmaine Coulen, MPH; Jan E. Berger, MD, MJ; Marsha C. Moore, MD, MBA; Angela McQueen, PharmD; and Saira

More information

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians Performance Measurement Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians Writing Committee Amir Qaseem, MD,

More information

The National Asthma Education and Prevention Program s

The National Asthma Education and Prevention Program s Long-Acting b-agonist Among Children and Adults With Asthma Elizabeth A. Wasilevich, PhD, MPH; Sarah J. Clark, MPH; Lisa M. Cohn, MS; and Kevin J. Dombkowski, DrPH Managed Care & Healthcare Communications,

More information

Medication compliance, or. Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia

Medication compliance, or. Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia Peter J. Weiden, M.D. Chris Kozma, Ph.D. Amy Grogg, Pharm.D. Julie Locklear, Pharm.D., M.B.A. Objective:

More information

Bundled Payments in Orthopedic Trauma: How to Succeed

Bundled Payments in Orthopedic Trauma: How to Succeed SE 87 Bundled Payments in Orthopedic Trauma: How to Succeed Sanjit R. Konda MD Ariana Lott BA Kurtis Carlock BS Kenneth A. Egol MD Department of Orthopedic Surgery NYU Langone Orthopedic Hospital, New

More information

1* 2 3. Hirva Bakeri, Dorothy Wakefield, Latha Dulipsingh. Department of Medicine, University of Connecticut Health Center, USA 2

1* 2 3. Hirva Bakeri, Dorothy Wakefield, Latha Dulipsingh. Department of Medicine, University of Connecticut Health Center, USA 2 RESEARCH ARTICLE Is There a Role of Hemoglobin A1C in Predicting Hospital Re- Admission Rates for Patients with Diabetes? 1* 2 3 Hirva Bakeri, Dorothy Wakefield, Latha Dulipsingh 1 Department of Medicine,

More information

Chapter 6: Healthcare Expenditures for Persons with CKD

Chapter 6: Healthcare Expenditures for Persons with CKD Chapter 6: Healthcare Expenditures for Persons with CKD In this 2017 Annual Data Report (ADR), we introduce information from the Optum Clinformatics DataMart for persons with Medicare Advantage and commercial

More information

NON-ADHERENCE TO ADJUVANT HORMONAL TREATMENT IN EARLY BREAST CANCER

NON-ADHERENCE TO ADJUVANT HORMONAL TREATMENT IN EARLY BREAST CANCER NON-ADHERENCE TO ADJUVANT HORMONAL TREATMENT IN EARLY BREAST CANCER C. Volovat 1, C. Lupascu 2, Simona-Ruxandra Volovat 1, E. Zbranca 3 1. Center of Medical Oncology Iasi 2. I. Tanasescu Vl. Butureanu

More information

Making the Business Case for Long-Acting Injectables

Making the Business Case for Long-Acting Injectables Making the Business Case for Long-Acting Injectables David R. Swann, MA, LCAS, CCS, LPC, NCC Senior Healthcare Integration Consultant MTM Services Chief Clinical Officer Partners Behavioral Health Management

More information

Assessing Medication Adherence

Assessing Medication Adherence Assessing Medication Adherence Dr. Lauren Hanna and Dr. Delbert Robinson Northwell Health National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental

More information

APPENDIX: Supplementary Materials for Advance Directives And Nursing. Home Stays Associated With Less Aggressive End-Of-Life Care For

APPENDIX: Supplementary Materials for Advance Directives And Nursing. Home Stays Associated With Less Aggressive End-Of-Life Care For Nicholas LH, Bynum JPW, Iwashnya TJ, Weir DR, Langa KM. Advance directives and nursing home stays associated with less aggressive end-of-life care for patients with severe dementia. Health Aff (MIllwood).

More information

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments Prepared for: American Hospital Association April 4, 2019 Berna Demiralp,

More information

Hospital Discharge Data

Hospital Discharge Data Hospital Discharge Data West Virginia Health Care Authority Hospitalization data were obtained from the West Virginia Health Care Authority s (WVHCA) hospital discharge database. Data are submitted by

More information

Delayed or missed follow-up of laboratory tests is

Delayed or missed follow-up of laboratory tests is Reports from the field Follow-up of Abnormal Metanephrine and Catecholamine Testing: Chasing Missed Neuroendocrine Tumors Richard Zamore, MD, MPH, Beth Harubin, MS, Megan Sweeney, BS, and Saul N. Weingart,

More information

Study Exposures, Outcomes:

Study Exposures, Outcomes: GSK Medicine: Coreg IR, Coreg CR, and InnoPran Study No.: WWE111944/WEUSRTP3149 Title: A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic

More information

had non-continuous enrolment in Medicare Part A or Part B during the year following initial admission;

had non-continuous enrolment in Medicare Part A or Part B during the year following initial admission; Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries Weiss J P, Saynina O, McDonald K M, McClellan M

More information

PQS Summary of Pharmacy/ Medication-Related Updates in the CY 2020 Final Call Letter

PQS Summary of Pharmacy/ Medication-Related Updates in the CY 2020 Final Call Letter Managing Performance Information in a Quality Driven World PQS Summary of Pharmacy/ Medication-Related Updates in the CY 2020 Final Call Letter REGULATORY UPDATE PQS Summary of Pharmacy/ Medication-Related

More information

Prospective Validation of Eight Different Adherence Measures for Use with Administrative Claims Data among Patients with Schizophreniavhe_

Prospective Validation of Eight Different Adherence Measures for Use with Administrative Claims Data among Patients with Schizophreniavhe_ Volume 12 Number 6 2009 VALUE IN HEALTH Prospective Validation of Eight Different Adherence Measures for Use with Administrative Claims Data among Patients with Schizophreniavhe_543 989..995 Sudeep Karve,

More information

eappendix A. Simulation study parameters

eappendix A. Simulation study parameters eappendix A. Simulation study parameters Parameter type Notation Values or distributions Definition i {1 20} Indicator for each of 20 monitoring periods N i 500*i Number of exposed patients in each period,

More information

Reducing the Risk of Stroke Associated With Nonvalvular Atrial Fibrillation in the VHA

Reducing the Risk of Stroke Associated With Nonvalvular Atrial Fibrillation in the VHA DECEMBER 21 VOL. 27 SUPPL. 1 A SUPPLEMENT TO www.fedprac.com Reducing the Risk of Stroke Associated With Nonvalvular Atrial Fibrillation in the VHA Diagnosing and Treating Atrial Fibrillation in the VHA

More information

Asthma Disease Management Demonstration Project:

Asthma Disease Management Demonstration Project: Asthma Disease Management Demonstration Project: Using EMS Health Coaches May Decrease Emergency Department Revisits, Length of Hospital Admissions and Costs Michael T. Hilton, MD Jan 13, 2012 NAEMSP Annual

More information

ATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE)

ATRIAL FIBRILLATION AND ETHNICITY. Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE) ATRIAL FIBRILLATION AND ETHNICITY Elsayed Z Soliman MD, MSc, MS Director, Epidemiological Cardiology Research Center (EPICARE) Atrial fibrillation (AF) and ethnicity The known The unknown The paradox Why

More information

Arkansas Blue Cross and Blue Shield (ABCBS) Patient Centered Medical Home (PCMH) Specifications Manual

Arkansas Blue Cross and Blue Shield (ABCBS) Patient Centered Medical Home (PCMH) Specifications Manual Arkansas Blue Cross and Blue Shield (ABCBS) Patient Centered Medical Home (PCMH) Specifications Manual 2017 This document is a guide to the 2017 Arkansas Blue Cross and Blue Shield Patient-Centered Medical

More information

COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS

COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS COMMUNITY ONCOLOGY ALLIANCE YOU WON T BELIEVE WHAT CMS WILL BE REPORTING ON YOUR ONCOLOGISTS Community Oncology Alliance 2 Physician Ratings Consumers want information about quality Have become used to

More information

Antidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors

Antidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors Antidepressant Use in ICU Survivors 1 Antidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors Sophia Wang, MD, Chris Mosher, MD, Sujuan Gao, PhD, Kayla Kirk, MA, Sue Lasiter, PhD, RN,

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority Quality ID #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety Meaningful Measure Area: Admissions and Readmissions to Hospitals 2019 COLLECTION

More information

REVIEW AND FREQUENTLY ASKED QUESTIONS (FAQ) 8/5/2015. Outline. Navigating the DSMT Reimbursement Maze in Todays Changing Environment

REVIEW AND FREQUENTLY ASKED QUESTIONS (FAQ) 8/5/2015. Outline. Navigating the DSMT Reimbursement Maze in Todays Changing Environment Patty Telgener RN, MBA, CPC VP of Reimbursement Emerson Consultants Navigating the DSMT Reimbursement Maze in Todays Changing Environment Patty Telgener, RN, MBA, CPC VP of Reimbursement Emerson Consultants

More information

Performance Analysis:

Performance Analysis: Performance Analysis: Healthcare Utilization of CCNC- Population 2007-2010 Prepared by Treo Solutions JUNE 2012 Table of Contents SECTION ONE: EXECUTIVE SUMMARY 4-5 SECTION TWO: REPORT DETAILS 6 Inpatient

More information

Factors Affecting Use of Insulin Pens by Patients with Type 2 Diabetes

Factors Affecting Use of Insulin Pens by Patients with Type 2 Diabetes Diabetes Care Publish Ahead of Print, published online November 26, 2007 Factors Affecting Use of Insulin Pens by Patients with Type 2 Diabetes Richard R. Rubin, PhD 1,2 Mark Peyrot, PhD 1,3 1= Department

More information

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES

SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES Summary Table of Measures, Product Lines and Changes 1 SUMMARY TABLE OF MEASURES, PRODUCT LINES AND CHANGES General Guidelines for Data Collection and Reporting Guidelines for Calculations and Sampling

More information

Functional status and social support network as risk factors for hospital readmission in Heart Failure

Functional status and social support network as risk factors for hospital readmission in Heart Failure Functional status and social support network as risk factors for hospital readmission in Heart Failure Sílvia Alexandra Duarte Centro Hospitalar de Trás os Montes e Alto Douro, Vila Real, Portugal CONFLICT

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set

More information

Chapter 2: Identification and Care of Patients With CKD

Chapter 2: Identification and Care of Patients With CKD Chapter 2: Identification and Care of Patients With CKD Over half of patients in the Medicare 5% sample (aged 65 and older) had at least one of three diagnosed chronic conditions chronic kidney disease

More information

Nonadherence to chronic medications contributes to

Nonadherence to chronic medications contributes to BRIEF REPORT Pharmacy-based Interventions to Reduce Primary Medication Nonadherence to Cardiovascular Medications Michael A. Fischer, MD, MS,* Niteesh K. Choudhry, MD, PhD,* Katsiaryna Bykov, PharmD, MS,*

More information

medicaid and the The Role of Medicaid for People with Diabetes

medicaid and the The Role of Medicaid for People with Diabetes on medicaid and the uninsured The Role of for People with Diabetes November 2012 Introduction Diabetes is one of the most prevalent chronic conditions and a leading cause of death in the United States.

More information

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care

David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care David Dosa MD, MPH Assistant Professor of Medicine and Community Health The Warren Alpert School of Medicine, Brown University Director, Primary Care Geriatrics Clinic- Providence VAMC VA Grand Rounds

More information

DUPLICATION DISTRIBUTION PROHIBBITED AND. Utilizing Economic and Clinical Outcomes to Eliminate Health Disparities and Improve Health Equity

DUPLICATION DISTRIBUTION PROHIBBITED AND. Utilizing Economic and Clinical Outcomes to Eliminate Health Disparities and Improve Health Equity General Session IV Utilizing Economic and Clinical Outcomes to Eliminate Health Disparities and Improve Health Equity Accreditation UAN 0024-0000-12-012-L04-P Participation in this activity earns 2.0 contact

More information

Heart Attack Readmissions in Virginia

Heart Attack Readmissions in Virginia Heart Attack Readmissions in Virginia Schroeder Center Statistical Brief Research by Mitchell Cole, William & Mary Public Policy, MPP Class of 2017 Highlights: In 2014, almost 11.2 percent of patients

More information

Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach

Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach Presented by Susan G. Haber, Sc.D 1 ; Boyd H. Gilman, Ph.D. 1 1 RTI International Presented at The 133rd Annual Meeting of

More information